Advertisement

Topics

Extended nivolumab followup shows durable response in relapsed cHL

07:01 EDT 20 Jun 2017 | ecancermedicalscience

Extended follow-up data has been released in which nivolumab demonstrated responses in adult patients with relapsed or progressed classical Hodgkin lymphoma (cHL) after autologous stem cell transplant (ASCT), irrespective of brentuximab vedotin (BV)...

Original Article: Extended nivolumab followup shows durable response in relapsed cHL

NEXT ARTICLE

More From BioPortfolio on "Extended nivolumab followup shows durable response in relapsed cHL"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Hodgkin lymphoma
Hodgkin Lymphoma is a  disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be limited to a single lymph node region (Stage 1) or spread...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...